Acadian Asset Management LLC Arbutus Biopharma Corp Transaction History

Acadian Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.65 - $4.62 $315,403 - $549,872	-119,020 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$2.5 - $3.51 $209,292 - $293,846	83,717 Added 237.14%	119,020 $361,000
Q1 2021 May 11, 2021	BUY	$3.14 - $4.84 $110,851 - $170,866	35,303 New	35,303 $118,000

138

95.5M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.